financetom
Business
financetom
/
Business
/
Firstcash Holdings Insider Sold Shares Worth $811,230, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Firstcash Holdings Insider Sold Shares Worth $811,230, According to a Recent SEC Filing
Sep 3, 2025 2:48 PM

05:22 PM EDT, 09/03/2025 (MT Newswires) -- R Douglas Orr, Executive Vice President & Chief Financial Officer, on September 02, 2025, sold 5,500 shares in Firstcash Holdings ( FCFS ) for $811,230. Following the Form 4 filing with the SEC, Orr has control over a total of 145,177 common shares of the company, with 97,567 shares held directly and 47,610 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/840489/000084048925000113/xslF345X05/wk-form4_1756933866.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palo Alto Networks Seeing Higher Momentum as Growth Seeds Lined Up for H2, Wedbush Says
Palo Alto Networks Seeing Higher Momentum as Growth Seeds Lined Up for H2, Wedbush Says
Feb 11, 2025
11:18 AM EST, 02/11/2025 (MT Newswires) -- Palo Alto Networks ( PANW ) is seeing higher momentum in the business around its cybersecurity platformization strategy and the growth seeds are now lined up for a very important H2, Wedbush said in a Tuesday note. The company is expected to provide a strong cybersecurity deal activity when it posts fiscal Q2...
Moleculin Biotech Receives Approval in Ukraine to Start Recruiting for Acute Myeloid Leukemia Phase 3 Trial
Moleculin Biotech Receives Approval in Ukraine to Start Recruiting for Acute Myeloid Leukemia Phase 3 Trial
Feb 11, 2025
11:18 AM EST, 02/11/2025 (MT Newswires) -- Moleculin Biotech ( MBRX ) said Tuesday it received regulatory approval in Ukraine to start recruiting for a phase 3 trial of annamycin plus cytarabine to treat relapsed or refractory acute myeloid leukemia, a type of cancer. The first 75 to 90 subjects in the trial's part A will receive high-dose cytarabine, or...
Fidelity National Information's Quarterly Revenue, 2025 Top-Line Outlook Miss Views
Fidelity National Information's Quarterly Revenue, 2025 Top-Line Outlook Miss Views
Feb 11, 2025
11:19 AM EST, 02/11/2025 (MT Newswires) -- Shares of Fidelity National Information Services ( FIS ) plunged intraday Tuesday after the financial technology company's top-line performance for the fourth quarter and its top-line outlook for the full year disappointed Wall Street's expectations. Revenue rose to $2.6 billion for the three months ended Dec. 31 from $2.51 billion a year ago,...
AI chip startup Positron raises $23.5 million seed round to take on Nvidia
AI chip startup Positron raises $23.5 million seed round to take on Nvidia
Feb 11, 2025
Positron, a startup chip maker that aims to compete with Nvidia ( NVDA ), said Tuesday it raised $23.5 million to scale production of its U.S.-made artificial intelligence chips.  Valor Equity Partners, known for backing Elon Musk's companies, Atreides Management, Flume Ventures and Resilience Reserve were among the investors who participated in the round. Reno-based Positron says its chips, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved